Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0372
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2010
Authors
Publisher
American Association for Cancer Research (AACR)